Option Care Health (NASDAQ:OPCH) Downgraded to “Hold” Rating by Wall Street Zen

Wall Street Zen downgraded shares of Option Care Health (NASDAQ:OPCH) from a buy rating to a hold rating in a report issued on Sunday.

Several other equities research analysts have also weighed in on the company. Barrington Research reissued an “outperform” rating and issued a $38.00 price objective on shares of Option Care Health in a report on Friday, October 31st. Bank of America increased their target price on shares of Option Care Health from $32.00 to $35.00 and gave the stock a “buy” rating in a research report on Tuesday, December 9th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Option Care Health from $31.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, December 9th. Stephens upgraded shares of Option Care Health to a “strong-buy” rating in a research note on Thursday. Finally, JMP Securities set a $36.00 price objective on shares of Option Care Health in a research note on Friday, October 31st. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Option Care Health presently has a consensus rating of “Moderate Buy” and an average price target of $36.27.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $33.24 on Friday. The company has a current ratio of 1.56, a quick ratio of 1.05 and a debt-to-equity ratio of 0.85. The stock has a fifty day simple moving average of $28.74 and a two-hundred day simple moving average of $29.32. Option Care Health has a 1-year low of $22.29 and a 1-year high of $35.53. The firm has a market cap of $5.28 billion, a price-to-earnings ratio of 26.38, a price-to-earnings-growth ratio of 2.24 and a beta of 0.79.

Insiders Place Their Bets

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 38,000 shares of the stock in a transaction on Monday, November 3rd. The shares were purchased at an average price of $25.98 per share, with a total value of $987,240.00. Following the acquisition, the director directly owned 413,390 shares in the company, valued at approximately $10,739,872.20. The trade was a 10.12% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.64% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of OPCH. USA Financial Formulas purchased a new position in Option Care Health in the 2nd quarter worth approximately $26,000. Cornerstone Planning Group LLC lifted its holdings in shares of Option Care Health by 7,621.4% during the 3rd quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock worth $30,000 after acquiring an additional 1,067 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its position in Option Care Health by 1,492.9% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company’s stock worth $31,000 after acquiring an additional 836 shares in the last quarter. Advisory Services Network LLC bought a new position in Option Care Health in the third quarter valued at $35,000. Finally, McIlrath & Eck LLC purchased a new stake in Option Care Health during the second quarter valued at about $37,000. 98.05% of the stock is currently owned by institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.